The global market for mRNA Shingles Vaccine was valued at US$ 347 million in the year 2024 and is projected to reach a revised size of US$ 485 million by 2031, growing at a CAGR of 5.4% during the forecast period.

mRNA Shingles Vaccine Market

The mRNA shingles vaccine is a vaccine developed using mRNA technology to prevent herpes zoster, commonly known as "shingles". Herpes zoster is caused by the reactivation of the varicella-zoster virus (VZV), typically manifesting as painful blisters on the skin. The mRNA shingles vaccine introduces mRNA encoding specific antigen proteins of the varicella-zoster virus into the human body, inducing human cells to produce these antigen proteins and subsequently stimulating the immune response to form long-term immune protection against the varicella-zoster virus. This vaccine offers advantages such as high efficacy, safety, and a short development cycle, providing an effective immune barrier for susceptible populations.

North American market for mRNA Shingles Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for mRNA Shingles Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of mRNA Shingles Vaccine include AIM Vaccine, Innorna, Moderna, Pfizer, SINOVAC, BioNTech, Immorna, Rhegen, GSK, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for mRNA Shingles Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding mRNA Shingles Vaccine.

The mRNA Shingles Vaccine market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global mRNA Shingles Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the mRNA Shingles Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of mRNA Shingles Vaccine Market Report

Report Metric	Details
Report Name	mRNA Shingles Vaccine Market
Accounted market size in year	US$ 347 million
Forecasted market size in 2031	US$ 485 million
CAGR	5.4%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Non Self Amplifying Type Self-Amplifying Type
Segment by Application	Hospital Clinic CDC Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	AIM Vaccine, Innorna, Moderna, Pfizer, SINOVAC, BioNTech, Immorna, Rhegen, GSK
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of mRNA Shingles Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of mRNA Shingles Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is mRNA Shingles Vaccine Market growing?

Ans: The mRNA Shingles Vaccine Market witnessing a CAGR of 5.4% during the forecast period 2025-2031.

What is the mRNA Shingles Vaccine Market size in 2031?

Ans: The mRNA Shingles Vaccine Market size in 2031 will be US$ 485 million.

Who are the main players in the mRNA Shingles Vaccine Market report?

Ans: The main players in the mRNA Shingles Vaccine Market are AIM Vaccine, Innorna, Moderna, Pfizer, SINOVAC, BioNTech, Immorna, Rhegen, GSK

What are the Application segmentation covered in the mRNA Shingles Vaccine Market report?

Ans: The Applications covered in the mRNA Shingles Vaccine Market report are Hospital, Clinic, CDC, Others

What are the Type segmentation covered in the mRNA Shingles Vaccine Market report?

Ans: The Types covered in the mRNA Shingles Vaccine Market report are Non Self Amplifying Type, Self-Amplifying Type

1 mRNA Shingles Vaccine Market Overview

1.1 Product Definition

1.2 mRNA Shingles Vaccine by Type

1.2.1 Global mRNA Shingles Vaccine Market Value Comparison by Type (2024 VS 2031)

1.2.2 Non Self Amplifying Type

1.2.3 Self-Amplifying Type

1.3 mRNA Shingles Vaccine by Application

1.3.1 Global mRNA Shingles Vaccine Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 CDC

1.3.5 Others

1.4 Global mRNA Shingles Vaccine Market Size Estimates and Forecasts

1.4.1 Global mRNA Shingles Vaccine Revenue 2020-2031

1.4.2 Global mRNA Shingles Vaccine Sales 2020-2031

1.4.3 Global mRNA Shingles Vaccine Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 mRNA Shingles Vaccine Market Competition by Manufacturers

2.1 Global mRNA Shingles Vaccine Sales Market Share by Manufacturers (2020-2025)

2.2 Global mRNA Shingles Vaccine Revenue Market Share by Manufacturers (2020-2025)

2.3 Global mRNA Shingles Vaccine Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of mRNA Shingles Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of mRNA Shingles Vaccine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of mRNA Shingles Vaccine, Product Type & Application

2.7 Global Key Manufacturers of mRNA Shingles Vaccine, Date of Enter into This Industry

2.8 Global mRNA Shingles Vaccine Market Competitive Situation and Trends

2.8.1 Global mRNA Shingles Vaccine Market Concentration Rate

2.8.2 The Global 5 and 10 Largest mRNA Shingles Vaccine Players Market Share by Revenue

2.8.3 Global mRNA Shingles Vaccine Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global mRNA Shingles Vaccine Market Scenario by Region

3.1 Global mRNA Shingles Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global mRNA Shingles Vaccine Sales by Region: 2020-2031

3.2.1 Global mRNA Shingles Vaccine Sales by Region: 2020-2025

3.2.2 Global mRNA Shingles Vaccine Sales by Region: 2026-2031

3.3 Global mRNA Shingles Vaccine Revenue by Region: 2020-2031

3.3.1 Global mRNA Shingles Vaccine Revenue by Region: 2020-2025

3.3.2 Global mRNA Shingles Vaccine Revenue by Region: 2026-2031

3.4 North America mRNA Shingles Vaccine Market Facts & Figures by Country

3.4.1 North America mRNA Shingles Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America mRNA Shingles Vaccine Sales by Country (2020-2031)

3.4.3 North America mRNA Shingles Vaccine Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe mRNA Shingles Vaccine Market Facts & Figures by Country

3.5.1 Europe mRNA Shingles Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe mRNA Shingles Vaccine Sales by Country (2020-2031)

3.5.3 Europe mRNA Shingles Vaccine Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific mRNA Shingles Vaccine Market Facts & Figures by Region

3.6.1 Asia Pacific mRNA Shingles Vaccine Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific mRNA Shingles Vaccine Sales by Region (2020-2031)

3.6.3 Asia Pacific mRNA Shingles Vaccine Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America mRNA Shingles Vaccine Market Facts & Figures by Country

3.7.1 Latin America mRNA Shingles Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America mRNA Shingles Vaccine Sales by Country (2020-2031)

3.7.3 Latin America mRNA Shingles Vaccine Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa mRNA Shingles Vaccine Market Facts & Figures by Country

3.8.1 Middle East and Africa mRNA Shingles Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa mRNA Shingles Vaccine Sales by Country (2020-2031)

3.8.3 Middle East and Africa mRNA Shingles Vaccine Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global mRNA Shingles Vaccine Sales by Type (2020-2031)

4.1.1 Global mRNA Shingles Vaccine Sales by Type (2020-2025)

4.1.2 Global mRNA Shingles Vaccine Sales by Type (2026-2031)

4.1.3 Global mRNA Shingles Vaccine Sales Market Share by Type (2020-2031)

4.2 Global mRNA Shingles Vaccine Revenue by Type (2020-2031)

4.2.1 Global mRNA Shingles Vaccine Revenue by Type (2020-2025)

4.2.2 Global mRNA Shingles Vaccine Revenue by Type (2026-2031)

4.2.3 Global mRNA Shingles Vaccine Revenue Market Share by Type (2020-2031)

4.3 Global mRNA Shingles Vaccine Price by Type (2020-2031)

5 Segment by Application

5.1 Global mRNA Shingles Vaccine Sales by Application (2020-2031)

5.1.1 Global mRNA Shingles Vaccine Sales by Application (2020-2025)

5.1.2 Global mRNA Shingles Vaccine Sales by Application (2026-2031)

5.1.3 Global mRNA Shingles Vaccine Sales Market Share by Application (2020-2031)

5.2 Global mRNA Shingles Vaccine Revenue by Application (2020-2031)

5.2.1 Global mRNA Shingles Vaccine Revenue by Application (2020-2025)

5.2.2 Global mRNA Shingles Vaccine Revenue by Application (2026-2031)

5.2.3 Global mRNA Shingles Vaccine Revenue Market Share by Application (2020-2031)

5.3 Global mRNA Shingles Vaccine Price by Application (2020-2031)

6 Key Companies Profiled

6.1 AIM Vaccine

6.1.1 AIM Vaccine Company Information

6.1.2 AIM Vaccine Description and Business Overview

6.1.3 AIM Vaccine mRNA Shingles Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.1.4 AIM Vaccine mRNA Shingles Vaccine Product Portfolio

6.1.5 AIM Vaccine Recent Developments/Updates

6.2 Innorna

6.2.1 Innorna Company Information

6.2.2 Innorna Description and Business Overview

6.2.3 Innorna mRNA Shingles Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Innorna mRNA Shingles Vaccine Product Portfolio

6.2.5 Innorna Recent Developments/Updates

6.3 Moderna

6.3.1 Moderna Company Information

6.3.2 Moderna Description and Business Overview

6.3.3 Moderna mRNA Shingles Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Moderna mRNA Shingles Vaccine Product Portfolio

6.3.5 Moderna Recent Developments/Updates

6.4 Pfizer

6.4.1 Pfizer Company Information

6.4.2 Pfizer Description and Business Overview

6.4.3 Pfizer mRNA Shingles Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Pfizer mRNA Shingles Vaccine Product Portfolio

6.4.5 Pfizer Recent Developments/Updates

6.5 SINOVAC

6.5.1 SINOVAC Company Information

6.5.2 SINOVAC Description and Business Overview

6.5.3 SINOVAC mRNA Shingles Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.5.4 SINOVAC mRNA Shingles Vaccine Product Portfolio

6.5.5 SINOVAC Recent Developments/Updates

6.6 BioNTech

6.6.1 BioNTech Company Information

6.6.2 BioNTech Description and Business Overview

6.6.3 BioNTech mRNA Shingles Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.6.4 BioNTech mRNA Shingles Vaccine Product Portfolio

6.6.5 BioNTech Recent Developments/Updates

6.7 Immorna

6.7.1 Immorna Company Information

6.7.2 Immorna Description and Business Overview

6.7.3 Immorna mRNA Shingles Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Immorna mRNA Shingles Vaccine Product Portfolio

6.7.5 Immorna Recent Developments/Updates

6.8 Rhegen

6.8.1 Rhegen Company Information

6.8.2 Rhegen Description and Business Overview

6.8.3 Rhegen mRNA Shingles Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Rhegen mRNA Shingles Vaccine Product Portfolio

6.8.5 Rhegen Recent Developments/Updates

6.9 GSK

6.9.1 GSK Company Information

6.9.2 GSK Description and Business Overview

6.9.3 GSK mRNA Shingles Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.9.4 GSK mRNA Shingles Vaccine Product Portfolio

6.9.5 GSK Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 mRNA Shingles Vaccine Industry Chain Analysis

7.2 mRNA Shingles Vaccine Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 mRNA Shingles Vaccine Production Mode & Process Analysis

7.4 mRNA Shingles Vaccine Sales and Marketing

7.4.1 mRNA Shingles Vaccine Sales Channels

7.4.2 mRNA Shingles Vaccine Distributors

7.5 mRNA Shingles Vaccine Customer Analysis

8 mRNA Shingles Vaccine Market Dynamics

8.1 mRNA Shingles Vaccine Industry Trends

8.2 mRNA Shingles Vaccine Market Drivers

8.3 mRNA Shingles Vaccine Market Challenges

8.4 mRNA Shingles Vaccine Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global mRNA Shingles Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global mRNA Shingles Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global mRNA Shingles Vaccine Market Competitive Situation by Manufacturers in 2024

Table 4. Global mRNA Shingles Vaccine Sales (Units) of Key Manufacturers (2020-2025)

Table 5. Global mRNA Shingles Vaccine Sales Market Share by Manufacturers (2020-2025)

Table 6. Global mRNA Shingles Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global mRNA Shingles Vaccine Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market mRNA Shingles Vaccine Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of mRNA Shingles Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of mRNA Shingles Vaccine, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of mRNA Shingles Vaccine, Product Type & Application

Table 12. Global Key Manufacturers of mRNA Shingles Vaccine, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global mRNA Shingles Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Shingles Vaccine as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global mRNA Shingles Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global mRNA Shingles Vaccine Sales by Region (2020-2025) & (Units)

Table 18. Global mRNA Shingles Vaccine Sales Market Share by Region (2020-2025)

Table 19. Global mRNA Shingles Vaccine Sales by Region (2026-2031) & (Units)

Table 20. Global mRNA Shingles Vaccine Sales Market Share by Region (2026-2031)

Table 21. Global mRNA Shingles Vaccine Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global mRNA Shingles Vaccine Revenue Market Share by Region (2020-2025)

Table 23. Global mRNA Shingles Vaccine Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global mRNA Shingles Vaccine Revenue Market Share by Region (2026-2031)

Table 25. North America mRNA Shingles Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America mRNA Shingles Vaccine Sales by Country (2020-2025) & (Units)

Table 27. North America mRNA Shingles Vaccine Sales by Country (2026-2031) & (Units)

Table 28. North America mRNA Shingles Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America mRNA Shingles Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe mRNA Shingles Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe mRNA Shingles Vaccine Sales by Country (2020-2025) & (Units)

Table 32. Europe mRNA Shingles Vaccine Sales by Country (2026-2031) & (Units)

Table 33. Europe mRNA Shingles Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe mRNA Shingles Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific mRNA Shingles Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific mRNA Shingles Vaccine Sales by Region (2020-2025) & (Units)

Table 37. Asia Pacific mRNA Shingles Vaccine Sales by Region (2026-2031) & (Units)

Table 38. Asia Pacific mRNA Shingles Vaccine Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific mRNA Shingles Vaccine Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America mRNA Shingles Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America mRNA Shingles Vaccine Sales by Country (2020-2025) & (Units)

Table 42. Latin America mRNA Shingles Vaccine Sales by Country (2026-2031) & (Units)

Table 43. Latin America mRNA Shingles Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America mRNA Shingles Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa mRNA Shingles Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa mRNA Shingles Vaccine Sales by Country (2020-2025) & (Units)

Table 47. Middle East and Africa mRNA Shingles Vaccine Sales by Country (2026-2031) & (Units)

Table 48. Middle East and Africa mRNA Shingles Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa mRNA Shingles Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global mRNA Shingles Vaccine Sales (Units) by Type (2020-2025)

Table 51. Global mRNA Shingles Vaccine Sales (Units) by Type (2026-2031)

Table 52. Global mRNA Shingles Vaccine Sales Market Share by Type (2020-2025)

Table 53. Global mRNA Shingles Vaccine Sales Market Share by Type (2026-2031)

Table 54. Global mRNA Shingles Vaccine Revenue (US$ Million) by Type (2020-2025)

Table 55. Global mRNA Shingles Vaccine Revenue (US$ Million) by Type (2026-2031)

Table 56. Global mRNA Shingles Vaccine Revenue Market Share by Type (2020-2025)

Table 57. Global mRNA Shingles Vaccine Revenue Market Share by Type (2026-2031)

Table 58. Global mRNA Shingles Vaccine Price (US$/Unit) by Type (2020-2025)

Table 59. Global mRNA Shingles Vaccine Price (US$/Unit) by Type (2026-2031)

Table 60. Global mRNA Shingles Vaccine Sales (Units) by Application (2020-2025)

Table 61. Global mRNA Shingles Vaccine Sales (Units) by Application (2026-2031)

Table 62. Global mRNA Shingles Vaccine Sales Market Share by Application (2020-2025)

Table 63. Global mRNA Shingles Vaccine Sales Market Share by Application (2026-2031)

Table 64. Global mRNA Shingles Vaccine Revenue (US$ Million) by Application (2020-2025)

Table 65. Global mRNA Shingles Vaccine Revenue (US$ Million) by Application (2026-2031)

Table 66. Global mRNA Shingles Vaccine Revenue Market Share by Application (2020-2025)

Table 67. Global mRNA Shingles Vaccine Revenue Market Share by Application (2026-2031)

Table 68. Global mRNA Shingles Vaccine Price (US$/Unit) by Application (2020-2025)

Table 69. Global mRNA Shingles Vaccine Price (US$/Unit) by Application (2026-2031)

Table 70. AIM Vaccine Company Information

Table 71. AIM Vaccine Description and Business Overview

Table 72. AIM Vaccine mRNA Shingles Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. AIM Vaccine mRNA Shingles Vaccine Product

Table 74. AIM Vaccine Recent Developments/Updates

Table 75. Innorna Company Information

Table 76. Innorna Description and Business Overview

Table 77. Innorna mRNA Shingles Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Innorna mRNA Shingles Vaccine Product

Table 79. Innorna Recent Developments/Updates

Table 80. Moderna Company Information

Table 81. Moderna Description and Business Overview

Table 82. Moderna mRNA Shingles Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Moderna mRNA Shingles Vaccine Product

Table 84. Moderna Recent Developments/Updates

Table 85. Pfizer Company Information

Table 86. Pfizer Description and Business Overview

Table 87. Pfizer mRNA Shingles Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Pfizer mRNA Shingles Vaccine Product

Table 89. Pfizer Recent Developments/Updates

Table 90. SINOVAC Company Information

Table 91. SINOVAC Description and Business Overview

Table 92. SINOVAC mRNA Shingles Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. SINOVAC mRNA Shingles Vaccine Product

Table 94. SINOVAC Recent Developments/Updates

Table 95. BioNTech Company Information

Table 96. BioNTech Description and Business Overview

Table 97. BioNTech mRNA Shingles Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. BioNTech mRNA Shingles Vaccine Product

Table 99. BioNTech Recent Developments/Updates

Table 100. Immorna Company Information

Table 101. Immorna Description and Business Overview

Table 102. Immorna mRNA Shingles Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Immorna mRNA Shingles Vaccine Product

Table 104. Immorna Recent Developments/Updates

Table 105. Rhegen Company Information

Table 106. Rhegen Description and Business Overview

Table 107. Rhegen mRNA Shingles Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Rhegen mRNA Shingles Vaccine Product

Table 109. Rhegen Recent Developments/Updates

Table 110. GSK Company Information

Table 111. GSK Description and Business Overview

Table 112. GSK mRNA Shingles Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. GSK mRNA Shingles Vaccine Product

Table 114. GSK Recent Developments/Updates

Table 115. Key Raw Materials Lists

Table 116. Raw Materials Key Suppliers Lists

Table 117. mRNA Shingles Vaccine Distributors List

Table 118. mRNA Shingles Vaccine Customers List

Table 119. mRNA Shingles Vaccine Market Trends

Table 120. mRNA Shingles Vaccine Market Drivers

Table 121. mRNA Shingles Vaccine Market Challenges

Table 122. mRNA Shingles Vaccine Market Restraints

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

Table 126. Authors List of This Report

List of Figures

Figure 1. Product Picture of mRNA Shingles Vaccine

Figure 2. Global mRNA Shingles Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global mRNA Shingles Vaccine Market Share by Type: 2024 & 2031

Figure 4. Non Self Amplifying Type Product Picture

Figure 5. Self-Amplifying Type Product Picture

Figure 6. Global mRNA Shingles Vaccine Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global mRNA Shingles Vaccine Market Share by Application: 2024 & 2031

Figure 8. Hospital

Figure 9. Clinic

Figure 10. CDC

Figure 11. Others

Figure 12. Global mRNA Shingles Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global mRNA Shingles Vaccine Market Size (2020-2031) & (US$ Million)

Figure 14. Global mRNA Shingles Vaccine Sales (2020-2031) & (Units)

Figure 15. Global mRNA Shingles Vaccine Average Price (US$/Unit) & (2020-2031)

Figure 16. mRNA Shingles Vaccine Report Years Considered

Figure 17. mRNA Shingles Vaccine Sales Share by Manufacturers in 2024

Figure 18. Global mRNA Shingles Vaccine Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest mRNA Shingles Vaccine Players: Market Share by Revenue in mRNA Shingles Vaccine in 2024

Figure 20. mRNA Shingles Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global mRNA Shingles Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America mRNA Shingles Vaccine Sales Market Share by Country (2020-2031)

Figure 23. North America mRNA Shingles Vaccine Revenue Market Share by Country (2020-2031)

Figure 24. United States mRNA Shingles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada mRNA Shingles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe mRNA Shingles Vaccine Sales Market Share by Country (2020-2031)

Figure 27. Europe mRNA Shingles Vaccine Revenue Market Share by Country (2020-2031)

Figure 28. Germany mRNA Shingles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France mRNA Shingles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. mRNA Shingles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy mRNA Shingles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia mRNA Shingles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific mRNA Shingles Vaccine Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific mRNA Shingles Vaccine Revenue Market Share by Region (2020-2031)

Figure 35. China mRNA Shingles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan mRNA Shingles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea mRNA Shingles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India mRNA Shingles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia mRNA Shingles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. China Taiwan mRNA Shingles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Southeast Asia mRNA Shingles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Latin America mRNA Shingles Vaccine Sales Market Share by Country (2020-2031)

Figure 43. Latin America mRNA Shingles Vaccine Revenue Market Share by Country (2020-2031)

Figure 44. Mexico mRNA Shingles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Brazil mRNA Shingles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Argentina mRNA Shingles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Colombia mRNA Shingles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Middle East and Africa mRNA Shingles Vaccine Sales Market Share by Country (2020-2031)

Figure 49. Middle East and Africa mRNA Shingles Vaccine Revenue Market Share by Country (2020-2031)

Figure 50. Turkey mRNA Shingles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia mRNA Shingles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. UAE mRNA Shingles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Global Sales Market Share of mRNA Shingles Vaccine by Type (2020-2031)

Figure 54. Global Revenue Market Share of mRNA Shingles Vaccine by Type (2020-2031)

Figure 55. Global mRNA Shingles Vaccine Price (US$/Unit) by Type (2020-2031)

Figure 56. Global Sales Market Share of mRNA Shingles Vaccine by Application (2020-2031)

Figure 57. Global Revenue Market Share of mRNA Shingles Vaccine by Application (2020-2031)

Figure 58. Global mRNA Shingles Vaccine Price (US$/Unit) by Application (2020-2031)

Figure 59. mRNA Shingles Vaccine Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Zoster Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Messenger RNA Vaccines and Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Shingles Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Veterinary mRNA Vaccines Market Research Report 2025

Global Varicella Live Vaccine Market Insights Forecast to 2030

Varicella Virus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Livestock mRNA Vaccines Market Research Report 2025

Global mRNA Vaccines for Animals Market Research Report 2025

Global Herpes Zoster Treatment Market Insights Forecast to 2030

Global mRNA Vaccines Therapeutics Market Research Report 2024

Global Recombinant Zoster Vaccine Market Research Report 2025

Global Herpes Simplex Virus HSV Vaccines Market Insights Forecast to 2030

Global mRNA Vaccine And Therapeutics Market Insights Forecast to 2030

Global RSV mRNA Vaccine Market Research Report 2025

Global Non Replicating mRNA Vaccine Market Research Report 2025

Live Attenuated Herpes Zoster Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Zoster Vaccine Live Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

mRNA Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

mRNA Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions